Condition
Ethamsylate Allergy
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
7 treatments under study, led by Tourniquet
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Tourniquet1
- Bupivacaine Hydrochloride 05 Injectable Solution Epinephrine1
- Carbetocin1
- Vasopressin1
- Oxytocin1
Active Sponsors
- Cairo University1
Top Investigators
Cairo University
Related Conditions
- Oxytocin Allergy1
- Tranexamic Acid Allergy1
- Misoprostol Allergy1
- Myoma1
- Blood Loss Surgical1